News and Trends 2 Apr 2020
iTeos Therapeutics’ Cancer Immunotherapy Boosted with €114M Funding
An oversubscribed Series B2 round has seen the biopharmaceutical company iTeos Therapeutics raise €114M, which will be used to advance the clinical development of its two lead cancer immunotherapies. The…